Literature DB >> 20444130

Extended wearing trial of Trifield lens device for 'tunnel vision'.

Russell L Woods1, Robert G Giorgi, Eliot L Berson, Eli Peli.   

Abstract

Severe visual field constriction (tunnel vision) impairs the ability to navigate and walk safely. We evaluated Trifield glasses as a mobility rehabilitation device for tunnel vision in an extended wearing trial. Twelve patients with tunnel vision (5-22 degrees wide) due to retinitis pigmentosa or choroideremia participated in the 5-visit wearing trial. To expand the horizontal visual field, one spectacle lens was fitted with two apex-to-apex prisms that vertically bisected the pupil on primary gaze. This provides visual field expansion at the expense of visual confusion (two objects with the same visual direction). Patients were asked to wear these spectacles as much as possible for the duration of the wearing trial (median 8, range 6-60 weeks). Clinical success (continued wear, indicating perceived overall benefit), visual field expansion, perceived direction and perceived visual ability were measured. Of 12 patients, nine chose to continue wearing the Trifield glasses at the end of the wearing trial. Of those nine patients, at long-term follow-up (35-78 weeks), three reported still wearing the Trifield glasses. Visual field expansion (median 18, range 9-38 degrees) was demonstrated for all patients. No patient demonstrated adaptation to the change in visual direction produced by the Trifield glasses (prisms). For reported difficulty with obstacles, some differences between successful and non-successful wearers were found. Trifield glasses provided reported benefits in obstacle avoidance to 7 of the 12 patients completing the wearing trial. Crowded environments were particularly difficult for most wearers. Possible reasons for long-term discontinuation and lack of adaptation to perceived direction are discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20444130      PMCID: PMC2867070          DOI: 10.1111/j.1475-1313.2010.00718.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  49 in total

1.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

2.  Vistech VCTS 6500 charts--within- and between-session reliability.

Authors:  B C Reeves; J M Wood; A R Hill
Journal:  Optom Vis Sci       Date:  1991-09       Impact factor: 1.973

3.  Visual correlates of obstacle avoidance in adults with low vision.

Authors:  T Kuyk; J L Elliott; P S Fuhr
Journal:  Optom Vis Sci       Date:  1998-03       Impact factor: 1.973

4.  Mobility performance in glaucoma.

Authors:  K A Turano; G S Rubin; H A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-11       Impact factor: 4.799

5.  Impaired vision and hip fracture. The Framingham Study.

Authors:  D T Felson; J J Anderson; M T Hannan; R C Milton; P W Wilson; D P Kiel
Journal:  J Am Geriatr Soc       Date:  1989-06       Impact factor: 5.562

6.  Alternating prism exposure causes dual adaptation and generalization to a novel displacement.

Authors:  R B Welch; B Bridgeman; S Anand; K E Browman
Journal:  Percept Psychophys       Date:  1993-08

7.  Disability and 6-year mortality in elderly population. Role of visual impairment.

Authors:  Francesco Cacciatore; Pasquale Abete; Stefania Maggi; Guido Luchetti; Claudio Calabrese; Luisa Viati; Dario Leosco; Nicola Ferrara; Dino Franco Vitale; Franco Rengo
Journal:  Aging Clin Exp Res       Date:  2004-10       Impact factor: 3.636

8.  Field expansion for homonymous hemianopia by optically induced peripheral exotropia.

Authors:  E Peli
Journal:  Optom Vis Sci       Date:  2000-09       Impact factor: 1.973

9.  Community-based trial of a peripheral prism visual field expansion device for hemianopia.

Authors:  Alex R Bowers; Karen Keeney; Eli Peli
Journal:  Arch Ophthalmol       Date:  2008-05

10.  Ocular dominance diagnosis and its influence in monovision.

Authors:  Olga Seijas; Pilar Gómez de Liaño; Rosario Gómez de Liaño; Clare J Roberts; Elena Piedrahita; Ester Diaz
Journal:  Am J Ophthalmol       Date:  2007-05-29       Impact factor: 5.258

View more
  6 in total

1.  Volume perimetry: measurement in depth of visual field loss.

Authors:  Premnandhini Satgunam; Henry L Apfelbaum; Eli Peli
Journal:  Optom Vis Sci       Date:  2012-09       Impact factor: 1.973

2.  Measuring Pedestrian Collision Detection With Peripheral Field Loss and the Impact of Peripheral Prisms.

Authors:  Cheng Qiu; Jae-Hyun Jung; Merve Tuccar-Burak; Lauren Spano; Robert Goldstein; Eli Peli
Journal:  Transl Vis Sci Technol       Date:  2018-09-04       Impact factor: 3.283

3.  The risk of pedestrian collisions with peripheral visual field loss.

Authors:  Eli Peli; Henry Apfelbaum; Eliot L Berson; Robert B Goldstein
Journal:  J Vis       Date:  2016-12-01       Impact factor: 2.240

4.  Validation of a vision-related activity scale for patients with retinitis pigmentosa.

Authors:  Francisco M Costela; Konrad Pesudovs; Michael A Sandberg; Carol Weigel-DiFranco; Russell L Woods
Journal:  Health Qual Life Outcomes       Date:  2020-06-22       Impact factor: 3.186

5.  Tunnel Vision Prismatic Field Expansion: Challenges and Requirements.

Authors:  Henry Apfelbaum; Eli Peli
Journal:  Transl Vis Sci Technol       Date:  2015-12-31       Impact factor: 3.283

6.  2017 Charles F. Prentice Award Lecture: Peripheral Prisms for Visual Field Expansion: A Translational Journey.

Authors:  Eli Peli
Journal:  Optom Vis Sci       Date:  2020-10       Impact factor: 2.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.